This is a fantastic achievement and demonstrates the ability of dmx200 to work as an adjuvant therapy alongside irbesartan. This has the potential to revolutionize CKD treatment. Amazing result and as you have said we are now a Phase 3 company on potentially multiple fronts!
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study, page-38
-
- There are more pages in this discussion • 249 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
-0.015(3.06%) |
Mkt cap ! $261.3M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 46.5¢ | $2.742M | 5.746M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158396 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 162500 | 2 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |